Total Funding
74
72
Total FundingVenture - Series Unknown raised
Growth Score
-8 pts
Heat Score
-7 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
32011
Sonic Incytes is a medical device start-up company targeting fatty liver disease
Tatagatha Ray: Manager of Business IntelligencePast Role: Smart Drivinc, Senior Scientist- George Aliphtiras: CEO & Co-Founder
About the Company
Sonic Incytes is the developer of Velacur, the first handheld diagnostic solution called Velacur for assessing liver attenuation with ultrasound, and liver stiffness with technology similar to that of MRI elastography, the current non-invasive gold standard. It aids in the clinical management of patients with liver disease, with measurements you
can count on.
